Teva recruits Tal Zaks to its board, offering $300K+ pay package and seamless transition from Moderna
Tal Zaks has found the first gig for his post-Moderna career — which will start just right after his last day at the mRNA powerhouse.
The seasoned exec has been recruited to the board at Teva, serving a one-year stint under chairman Sol Barer as an independent director starting Oct. 1. As announced earlier this year, his departure from Moderna is scheduled for late September, five and a half years since he was first appointed CMO.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.